Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complications
出版年份 2023 全文链接
标题
Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complications
作者
关键词
-
出版物
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Canadian Science Publishing
发表日期
2023-09-26
DOI
10.1139/cjpp-2023-0223
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The efficacy of PCSK9 inhibitors on major cardiovascular events and lipid profile in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2023) Egidio Imbalzano et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- (2023) Mihaela Simona Popoviciu et al. Journal of Personalized Medicine
- PCSK9 participates in oxidized‐low density lipoprotein‐induced myocardial injury through mitochondrial oxidative stress and Drp1‐mediated mitochondrial fission
- (2022) Xuan Li et al. Clinical and Translational Medicine
- Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population
- (2022) Yiming Wu et al. Frontiers in Endocrinology
- Insight into the Evolving Role of PCSK9
- (2022) Mateusz Maligłówka et al. Metabolites
- PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis
- (2022) Xing Wang et al. Cardiovascular Diabetology
- Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis
- (2022) Algerta Marku et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- PCSK9: A emerging participant in heart failure
- (2022) Qian Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- PCSK9 inhibitor inclisiran for treating atherosclerosis via regulation of endothelial cell pyroptosis
- (2022) Ni Kong et al. Annals of Translational Medicine
- Impact of PCSK9 on CTRP9-Induced Metabolic Effects in Adult Rat Cardiomyocytes
- (2021) Susanne Rohrbach et al. Frontiers in Physiology
- PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
- (2021) Aureli Luquero et al. Frontiers in Cardiovascular Medicine
- PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction
- (2021) Lorenzo Da Dalt et al. EUROPEAN HEART JOURNAL
- Diabetes insipidus
- (2021) Mirjam Christ-Crain et al. PRESSE MEDICALE
- Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
- (2020) Yi Tan et al. Nature Reviews Cardiology
- A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α
- (2020) Xuelei Wang et al. EBioMedicine
- The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases
- (2020) Chandrakala Aluganti Narasimhulu et al. Cells
- Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
- (2020) Ying Tang et al. Cardiovascular Diabetology
- The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion
- (2020) Shi-jun Deng et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- An Update on the Role of PCSK9 in Atherosclerosis
- (2020) Ece Yurtseven et al. Journal of Atherosclerosis and Thrombosis
- PCSK9 and atherosclerosis: Looking beyond LDL regulation
- (2020) Rosetta Ragusa et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
- (2019) Davide Di Fusco et al. Frontiers in Pharmacology
- Cardiomyopathy in obesity, insulin resistance or diabetes
- (2019) Michinari Nakamura et al. JOURNAL OF PHYSIOLOGY-LONDON
- Randomised Study of Evolocumab in Patients With Type 2 Diabetes and Dyslipidaemia on Background Statin: Primary Results of the BERSON Clinical Trial
- (2019) Alberto J. Lorenzatti et al. DIABETES OBESITY & METABOLISM
- Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
- (2019) Oliver Schnell et al. Cardiovascular Diabetology
- Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte
- (2019) Tiziana Filardi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment
- (2019) Tatsuhiko Urakami Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Targeting PCSK9: Implications for basic science and upcoming challenges
- (2019) Toshiyuki Nishikido et al. BRITISH JOURNAL OF PHARMACOLOGY
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
- (2019) Siripong Palee et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mitochondrial connexin 43 in sex-dependent myocardial responses and estrogen-mediated cardiac protection following acute ischemia/reperfusion injury
- (2019) Meijing Wang et al. BASIC RESEARCH IN CARDIOLOGY
- Mechanisms and regulation of cholesterol homeostasis
- (2019) Jie Luo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy
- (2018) Maura Knapp et al. ACTA PHARMACOLOGICA SINICA
- PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions
- (2018) Mika Hilvo et al. ATHEROSCLEROSIS
- PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy
- (2018) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- PCSK9
- (2018) Michael D. Shapiro et al. CIRCULATION RESEARCH
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- PCSK9: A potential regulator of apoE/apoER2 against inflammation in atherosclerosis?
- (2018) Xue-qin Bai et al. CLINICA CHIMICA ACTA
- PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
- (2018) Lorenzo Da Dalt et al. EUROPEAN HEART JOURNAL
- PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque
- (2018) A. Liu et al. JOURNAL OF INTERNAL MEDICINE
- The Evolving Future of PCSK9 Inhibitors
- (2018) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Beyond LDL: What Role for PCSK9 in Triglyceride-Rich Lipoprotein Metabolism?
- (2018) Wieneke Dijk et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PCSK9 induces a pro-inflammatory response in macrophages
- (2018) Chiara Ricci et al. Scientific Reports
- PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
- (2018) Yehuda Handelsman et al. Journal of the American Heart Association
- The cargo receptor SURF4 promotes the efficient cellular secretion of PCSK9
- (2018) Brian T Emmer et al. eLife
- The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine
- (2018) Xueling Ma et al. Frontiers in Pharmacology
- Of mice and men: models and mechanisms of diabetic cardiomyopathy
- (2018) Christian Riehle et al. BASIC RESEARCH IN CARDIOLOGY
- Small molecules as inhibitors of PCSK9: Current status and future challenges
- (2018) Shengtao Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women
- (2017) Amy E. Levenson et al. PEDIATRIC DIABETES
- On type 1 diabetes mellitus pathogenesis
- (2017) Stavroula A Paschou et al. Endocrine Connections
- PCSK9 signaling pathways and their potential importance in clinical practice
- (2017) Michał Wiciński et al. EPMA Journal
- Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?
- (2016) Yajnavalka Banerjee et al. ATHEROSCLEROSIS
- Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism
- (2016) Blake J. Cochran et al. DIABETES
- No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies
- (2016) Helen M. Colhoun et al. EUROPEAN HEART JOURNAL
- Leptin decreases the expression of low-density lipoprotein receptor via PCSK9 pathway: linking dyslipidemia with obesity
- (2016) Ying Du et al. Journal of Translational Medicine
- PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse LiverSignificance
- (2015) Annie Demers et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Role of Insulin in the Regulation of Proprotein Convertase Subtilisin/Kexin Type 9Significance
- (2015) Ji Miao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition
- (2015) Nathalie Bergeron et al. CIRCULATION
- Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients
- (2015) Ymène Nekaies et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Local effects of human PCSK9 on the atherosclerotic lesion
- (2015) Ilaria Giunzioni et al. JOURNAL OF PATHOLOGY
- PCSK9 inhibition to reduce cardiovascular disease risk
- (2015) Hagai Tavori et al. Current Opinion in Endocrinology Diabetes and Obesity
- BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy
- (2014) Princess Urbina et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Protein Sorting at the trans-Golgi Network
- (2014) Yusong Guo et al. Annual Review of Cell and Developmental Biology
- PCSK9: From discovery to therapeutic applications
- (2014) Michel Farnier Archives of Cardiovascular Diseases
- The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion
- (2014) Camilla Gustafsen et al. Cell Metabolism
- Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
- (2014) Qiurong Ding et al. CIRCULATION RESEARCH
- Mechanism linking diabetes mellitus and obesity
- (2014) Abdullah Algoblan et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The Emerging Global Epidemic of Type 1 Diabetes
- (2013) Jaakko Tuomilehto Current Diabetes Reports
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
- (2013) Marina Bayeva et al. Journal of the American Heart Association
- Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart
- (2012) E. Dale Abel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diabetic Complications: Current Challenges and Opportunities
- (2012) Helen D. Nickerson et al. Journal of Cardiovascular Translational Research
- Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study
- (2011) M.C.G.J. Brouwers et al. ATHEROSCLEROSIS
- Clinical aspects of PCSK9
- (2011) Bertrand Cariou et al. ATHEROSCLEROSIS
- LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications
- (2011) Meiling Yan et al. CARDIOVASCULAR DRUGS AND THERAPY
- Induced Pluripotent Stem (iPS) Cells Inhibit Apoptosis and Fibrosis in Streptozotocin-Induced Diabetic Rats
- (2011) Sarah Neel et al. MOLECULAR PHARMACEUTICS
- Stem cells in the diabetic infarcted heart
- (2010) Carley E. Glass et al. HEART FAILURE REVIEWS
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cells
- (2010) Hong Lan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Adnectins: engineered target-binding protein therapeutics
- (2010) D. Lipovsek PROTEIN ENGINEERING DESIGN & SELECTION
- Diagnosis and Classification of Diabetes Mellitus
- (2009) DIABETES CARE
- PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities
- (2009) Majambu Mbikay et al. FEBS LETTERS
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis
- (2009) S. A. Mousavi et al. JOURNAL OF INTERNAL MEDICINE
- Diabetic Cardiomyopathy: Insights into Pathogenesis, Diagnostic Challenges, and Therapeutic Options
- (2008) Ashish Aneja et al. AMERICAN JOURNAL OF MEDICINE
- Errata.PCSK9 function and physiology: Fig. 1.
- (2008) Andrew S. Peterson et al. JOURNAL OF LIPID RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now